CVSA (Covista Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by CVSA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | MICHAEL W MALAFRONTE | Director | G | — | — |
| 2026-08-28 | Manjunath Gangadharan | VP, Chief Accounting Officer | Sell | — | — |
| 2026-08-25 | Manjunath Gangadharan | VP, Chief Accounting Officer | MIXED | — | — |
| 2026-08-25 | Stephen W. Beard | Chairman & CEO | MIXED | — | — |
| 2026-08-25 | Robert J. Phelan | Chief Financial Officer | MIXED | — | — |
| 2026-08-25 | Michael Betz | Pres. Walden University & CDO | MIXED | — | — |
| 2026-08-25 | DOUGLAS G. BECK | SVP, GC, Corp. Sec & ISS | MIXED | — | — |
| 2026-08-13 | Stephen W. Beard | Chairman & CEO | Sell | — | — |
| 2026-08-11 | Robert J. Phelan | Chief Financial Officer | Sell | — | — |
| 2026-08-11 | DOUGLAS G. BECK | SVP, GC, Corp. Sec & ISS | Sell | — | — |
| 2026-07-16 | Amelia Manning | President, Chamberlain Univ. | A | — | — |
| 2026-07-15 | Stephen W. Beard | Chairman & CEO | Sell | — | — |
| 2026-07-09 | Robert J. Phelan | Chief Financial Officer | Sell | — | — |
| 2026-07-09 | DOUGLAS G. BECK | SVP, GC, Corp. Sec & ISS | Sell | — | — |
| 2026-06-12 | Stephen W. Beard | Chairman & CEO | Sell | — | — |
| 2026-05-20 | Manjunath Gangadharan | VP, Chief Accounting Officer | F | — | — |
| 2026-05-12 | Stephen W. Beard | Chairman & CEO | Sell | — | — |
| 2026-05-12 | DOUGLAS G. BECK | SVP, GC, Corp. Sec & ISS | Sell | — | — |
| 2026-05-12 | Karen Sue Cox | President, Chamberlain Univ. | Sell | — | — |
| 2026-05-12 | Robert J. Phelan | Chief Financial Officer | Sell | — | — |
| 2026-04-16 | Scott Liles | President, Medical and Vet | F | — | — |
| 2026-03-12 | MICHAEL W MALAFRONTE | Director | Buy | — | — |
| 2026-03-05 | MICHAEL W MALAFRONTE | Director | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chairman & CEO | 435,177 | — |
| — | Director | 136,100 | — |
| — | Chief Financial Officer | 54,083 | — |
| — | Pres. Walden University & CDO | 41,483 | — |
| — | SVP, GC, Corp. Sec & ISS | 32,002 | — |
| — | President, Chamberlain Univ. | 31,596 | — |
| — | President, Medical and Vet | 13,103 | — |
| — | VP, Chief Accounting Officer | 5,083 | — |
| — | President, Chamberlain Univ. | 4,317 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CVSA quote page; the site-wide leaderboard is on the insider transactions hub.